NeoMed launches brain tumour therapy fund

The UK-focused vehicle, named The Brain Tumour Fund, has received a £10m commitment from The Brain Tumour Charity, which is acting as a cornerstone investor.

The fund, which has a target of £60-80m, will invest in companies developing products or technology to reduce the debilitating effects of the disease and improve survival rates. It will consider investments in businesses with products in the pre-clinical, clinical trial and commercial stages of development.

The latest fund launch comes two years after Neomed held a final close for its fifth vehicle on €92.1m. Neomed Innovation V is now fully invested across 12 companies, most recently taking part in a $29m funding round for Ireland-based 4Tech, which specialises in the treatment of tricuspid regurgitation.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Funds
• Venture
• UK / Ireland
• Healthcare
• Venture
• United Kingdom
• Neomed Innovations